|Articles|November 29, 2004

RFID Story

RFID

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

Midyear 2026 Check-In: Megha Sinha on Pharma's AI Skills Gap

ByMegha Sinha,Zachary Zubulake

July 21st 2026

Woman holding multiple GLP-1 injection pens, weight loss and diabetes treatment concept | Image Credit: ©Kateryna -stock.adobe.com

Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data

BySusan Haigney

July 21st 2026

PharmTech Weekly Roundup—July 17, 2026

BySusan Haigney

July 20th 2026

Brent Wilhelm, Senior Vice President of Global Supply Chain, Cencora

Can AI Fix Pharma's Last-Mile Delivery Blind Spot?

ByBrent Wilhelm,Zachary Zubulake

July 20th 2026

From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing's First Half of 2026

ByMike Stenberg

July 17th 2026

RFID Story

Related Content

Midyear 2026 Check-In: Megha Sinha on Pharma's AI Skills Gap

Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data

PharmTech Weekly Roundup—July 17, 2026

Can AI Fix Pharma's Last-Mile Delivery Blind Spot?

From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing's First Half of 2026

Trending on Pharmaceutical Technology

Everything to Know about BMS & NVidia’s AI Supercomputer

Can AI Fix Pharma's Last-Mile Delivery Blind Spot?

Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data

From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing's First Half of 2026

PharmTech Weekly Roundup—July 17, 2026